485 related articles for article (PubMed ID: 31780644)
21. Targeting p63 Upregulation Abrogates Resistance to MAPK Inhibitors in Melanoma.
Patel A; Garcia LF; Mannella V; Gammon L; Borg TM; Maffucci T; Scatolini M; Chiorino G; Vergani E; Rodolfo M; Maurichi A; Posch C; Matin RN; Harwood CA; Bergamaschi D
Cancer Res; 2020 Jun; 80(12):2676-2688. PubMed ID: 32291316
[TBL] [Abstract][Full Text] [Related]
22. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of endoplasmic reticulum stress-induced autophagy sensitizes melanoma cells to temozolomide treatment.
Ryabaya O; Prokofieva A; Khochenkov D; Abramov I; Zasedatelev A; Stepanova E
Oncol Rep; 2018 Jul; 40(1):385-394. PubMed ID: 29749510
[TBL] [Abstract][Full Text] [Related]
24. ER stress promotes antitumor effects in BRAFi/MEKi resistant human melanoma induced by natural compound 4-nerolidylcathecol (4-NC).
Alves-Fernandes DK; Oliveira ÉA; Faião-Flores F; Alicea-Rebecca G; Weeraratna AT; Smalley KSM; Barros SBM; Maria-Engler SS
Pharmacol Res; 2019 Mar; 141():63-72. PubMed ID: 30550954
[TBL] [Abstract][Full Text] [Related]
25. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death.
Kapralov AA; Yang Q; Dar HH; Tyurina YY; Anthonymuthu TS; Kim R; St Croix CM; Mikulska-Ruminska K; Liu B; Shrivastava IH; Tyurin VA; Ting HC; Wu YL; Gao Y; Shurin GV; Artyukhova MA; Ponomareva LA; Timashev PS; Domingues RM; Stoyanovsky DA; Greenberger JS; Mallampalli RK; Bahar I; Gabrilovich DI; Bayır H; Kagan VE
Nat Chem Biol; 2020 Mar; 16(3):278-290. PubMed ID: 32080625
[TBL] [Abstract][Full Text] [Related]
26. Alkylating Agent-Induced NRF2 Blocks Endoplasmic Reticulum Stress-Mediated Apoptosis via Control of Glutathione Pools and Protein Thiol Homeostasis.
Zanotto-Filho A; Masamsetti VP; Loranc E; Tonapi SS; Gorthi A; Bernard X; Gonçalves RM; Moreira JC; Chen Y; Bishop AJ
Mol Cancer Ther; 2016 Dec; 15(12):3000-3014. PubMed ID: 27638861
[TBL] [Abstract][Full Text] [Related]
27. Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq.
Gerber T; Willscher E; Loeffler-Wirth H; Hopp L; Schadendorf D; Schartl M; Anderegg U; Camp G; Treutlein B; Binder H; Kunz M
Oncotarget; 2017 Jan; 8(1):846-862. PubMed ID: 27903987
[TBL] [Abstract][Full Text] [Related]
28. Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways.
Chiu CS; Tsai CH; Hsieh MS; Tsai SC; Jan YJ; Lin WY; Lai DW; Wu SM; Hsing HY; Arbiser JL; Sheu ML
Cancer Lett; 2019 Feb; 442():113-125. PubMed ID: 30391358
[TBL] [Abstract][Full Text] [Related]
29. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses.
Ou Y; Wang SJ; Li D; Chu B; Gu W
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6806-E6812. PubMed ID: 27698118
[TBL] [Abstract][Full Text] [Related]
30. Triggered ferroptotic polymer micelles for reversing multidrug resistance to chemotherapy.
Gao M; Deng J; Liu F; Fan A; Wang Y; Wu H; Ding D; Kong D; Wang Z; Peer D; Zhao Y
Biomaterials; 2019 Dec; 223():119486. PubMed ID: 31520887
[TBL] [Abstract][Full Text] [Related]
31. Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis.
Chang LC; Chiang SK; Chen SE; Yu YL; Chou RH; Chang WC
Cancer Lett; 2018 Mar; 416():124-137. PubMed ID: 29274359
[TBL] [Abstract][Full Text] [Related]
32. Impact of BRAF kinase inhibitors on the miRNomes and transcriptomes of melanoma cells.
Kozar I; Cesi G; Margue C; Philippidou D; Kreis S
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt B):2980-2992. PubMed ID: 28408301
[TBL] [Abstract][Full Text] [Related]
33. Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response‑induced upregulation of CHAC1 expression.
Wang Z; Li M; Liu Y; Qiao Z; Bai T; Yang L; Liu B
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34558645
[TBL] [Abstract][Full Text] [Related]
34. The plasma membrane Ca
Hegedũs L; Garay T; Molnár E; Varga K; Bilecz Á; Török S; Padányi R; Pászty K; Wolf M; Grusch M; Kállay E; Döme B; Berger W; Hegedũs B; Enyedi A
Int J Cancer; 2017 Jun; 140(12):2758-2770. PubMed ID: 27813079
[TBL] [Abstract][Full Text] [Related]
35. Role of Human Aldo-Keto Reductases and Nuclear Factor Erythroid 2-Related Factor 2 in the Metabolic Activation of 1-Nitropyrene via Nitroreduction in Human Lung Cells.
Su AL; Penning TM
Chem Res Toxicol; 2023 Feb; 36(2):270-280. PubMed ID: 36693016
[TBL] [Abstract][Full Text] [Related]
36. Boosting the Ferroptotic Antitumor Efficacy via Site-Specific Amplification of Tailored Lipid Peroxidation.
An Y; Zhu J; Liu F; Deng J; Meng X; Liu G; Wu H; Fan A; Wang Z; Zhao Y
ACS Appl Mater Interfaces; 2019 Aug; 11(33):29655-29666. PubMed ID: 31359759
[TBL] [Abstract][Full Text] [Related]
37. Targeted inhibition of metastatic melanoma through interference with Pin1-FOXM1 signaling.
Kruiswijk F; Hasenfuss SC; Sivapatham R; Baar MP; Putavet D; Naipal KA; van den Broek NJ; Kruit W; van der Spek PJ; van Gent DC; Brenkman AB; Campisi J; Burgering BM; Hoeijmakers JH; de Keizer PL
Oncogene; 2016 Apr; 35(17):2166-77. PubMed ID: 26279295
[TBL] [Abstract][Full Text] [Related]
38. 17-Aminogeldanamycin selectively diminishes IRE1α-XBP1s pathway activity and cooperatively induces apoptosis with MEK1/2 and BRAF
Mielczarek-Lewandowska A; Sztiller-Sikorska M; Osrodek M; Czyz M; Hartman ML
Apoptosis; 2019 Aug; 24(7-8):596-611. PubMed ID: 30989459
[TBL] [Abstract][Full Text] [Related]
39. ChaC glutathione specific γ-glutamylcyclotransferase 1 inhibits cell viability and increases the sensitivity of prostate cancer cells to docetaxel by inducing endoplasmic reticulum stress and ferroptosis.
He S; Zhang M; Ye Y; Zhuang J; Ma X; Song Y; Xia W
Exp Ther Med; 2021 Sep; 22(3):997. PubMed ID: 34345279
[TBL] [Abstract][Full Text] [Related]
40. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin.
Liu Q; Wang K
Cell Biol Int; 2019 Nov; 43(11):1245-1256. PubMed ID: 30811078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
